Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01660412 · ClinicalTrials.gov registry record · NA
Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01660412 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 60 participants.
The verdict
NCT01660412, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Pain during nuclear medicine breast lymphnode detection procedures has been reported as high as 8.8/10. Using Sodium Bicarbonate to alkalinize the radio-pharmaceutical injection, pain can safely be reduced from 6.6/10 to 4.7/10, during breast lymph node detection procedures. In sites other then the breast, using Bicarbonate to make the injection's pH closer to natural, attempts to lower the pain levels will be performed. Hypothesis: The perceived pain level during non breast sentinel lymph node techniques can be reduced by raising the pH of the injectate (Tc-99m SC) to near the physiologic level of pH 7.40.
Interventions
- DRUG Standard of Care First
- DRUG ph Altered first
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-08-01 |
| Est. Completion | 2016-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01660412
The ClinicalTrials.gov registry entry for NCT01660412 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care First is the first listed.
NCT01660412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01660412 about?
NCT01660412 is a clinical study titled "Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?". Pain during nuclear medicine breast lymphnode detection procedures has been reported as high as 8.8/10. Using Sodium Bicarbonate to alkalinize the radio-pharmaceutical injection, pain can safely be reduced from 6.6/10 to 4.7/10, during breast lymph node detection procedures. In sites other then the...
What is the current status of trial NCT01660412?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-08-01. Estimated completion is 2016-12-30.
What interventions are being tested in trial NCT01660412?
The interventions under investigation include: Standard of Care First (DRUG), ph Altered first (DRUG).
Who is sponsoring clinical trial NCT01660412?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.